Urgent.News

What's breaking now, across thousands of outlets.

AI

Anthropic’s one-person biotech buy; Jake Van Naarden’s dealmaking strategy; and more

Hello and welcome back to a spooky Halloween edition of Endpoints Weekly! Sorry to all the candy corn lovers out there, but just noting that they’re actually made with bug secretions. The Atlantic has all ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in AI

Anthropic's IPO push includes a big bet on life sciences

Anthropic's S-1 filing says Claude can accelerate drug discovery and biology research, making life sciences central to the AI company's IPO pitch.

  • Anthropic shifting focus from coding to life sciences for IPO
  • AI models to aid drug discovery and development in biotech
  • $400 million acquisition of Coefficient Bio for life sciences

More from Saturday 31 October →